Introduction {#sec1-1}
============

The increase in size of gingiva is usually termed as gingival enlargements or gingival overgrowths and often associated with myriad of clinical presentations. They usually represent the reactive hyperplasia to dental plaque accumulation.\[[@ref1][@ref2]\] Plaque-induced gingival enlargement usually resolves with the proper plaque debridement. However, a small group of localized gingival enlargements may present the reactive/inflammatory hyperplasia resulting in nodular growths which histologically may present with myriad of additional features forming a wide range of differential diagnosis.\[[@ref3][@ref4][@ref5][@ref6]\]

Localized gingival enlargements historically have been termed epulides, a term describing pedunculated or sessile swellings of the gingiva with no specific histologic characterization.\[[@ref7]\] However, nowadays, the term "epulides" has been replaced with focal reactive overgrowths as the etiological, clinical, and treatment modalities of these growths appear to be the same with slight variations.\[[@ref8]\] This paper will highlight about the varied clinical presentations of localized gingival overgrowths with different histopathological characteristics giving each of them a unique nomenclature.

Case Reports {#sec1-2}
============

Several patients were reported in the hospital outpatient department in West Bengal with the chief complaints of gum swellings presenting within the mouth for varied durations. The medical histories were found to be noncontributory upon investigations in all patients. On examination, solitary isolated gingival growths were observed in all the patients in different parts of the maxilla and mandible \[Figures [1](#F1){ref-type="fig"}-[6](#F6){ref-type="fig"}\]. The detailed case reports for every case were summarized in [Table 1](#T1){ref-type="table"}. All these gingival lesions were surgically excised after elevation of full-thickness mucoperiosteal flaps. The areas were undergone thorough debridement, and sutures were given after achieving proper hemostasis. The excised tissue was then sent for biopsy, and based on histopathological examinations, a wide range of diagnosis was made ranging from peripheral fibroma to pyogenic granuloma to peripheral fibroma with ossification and/or calcification, peripheral giant cell granuloma, and peripheral ameloblastoma. All the patients were advised for periodic checkups, and no recurrence was reported till date.

![(a) Clinical presentation of peripheral fibroma. (b) Excised tissue. (c) Histopathological features suggestive of peripheral fibroma](CCD-8-667-g001){#F1}

![(a) Clinical presentation of pyogenic granuloma. (b) Excised tissue. (c) Histopathological features suggestive of pyogenic granuloma](CCD-8-667-g002){#F2}

![(a) Clinical presentation of peripheral ossifying fibroma. (b) Excised tissue. (c) Histopathological features suggestive of peripheral ossifying fibroma](CCD-8-667-g003){#F3}

![(a) Clinical presentation of peripheral fibroma with calcification. (b) Excised tissue. (c) Histopathological features suggestive of peripheral fibroma with calcification](CCD-8-667-g004){#F4}

![(a) Clinical presentation of peripheral giant cell granuloma. (b) Excised tissue. (c) Histopathological features suggestive of peripheral giant cell granuloma](CCD-8-667-g005){#F5}

![(a) Clinical presentation of peripheral ameloblastoma. (b) Excised tissue. (c) Histopathological features suggestive of peripheral ameloblastoma](CCD-8-667-g006){#F6}
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Clinical presentation of cases

![](CCD-8-667-g007)

Discussion {#sec1-3}
==========

Localized gingival overgrowths usually present with a wide variety of clinical and histopathological features giving each of them a unique clinical identity. These localized gingival enlargements have been clinically grouped as focal reactive overgrowths as these growths are reactive gingival responses to chronic, low-grade irritation caused by plaque and calculus or any other irritant.\[[@ref8][@ref9]\] However, histopathologically, they may differ based on duration of the lesion and intensity of inflammation.\[[@ref9]\] However, within these groups, the peripheral fibroma is most commonly encountered, followed by pyogenic granuloma, peripheral fibroma with calcification, peripheral giant cell granuloma, and the peripheral ameloblastoma.\[[@ref2][@ref3][@ref4][@ref5][@ref6]\] They can usually occur at any site along the free gingival margin and characteristically grow out from the gingival sulcus with a cervical displacement of the gingival margin.\[[@ref2][@ref4]\] The male-to-female distribution ratio may range from 1:1.31 for peripheral fibroma to 1:1.99 for angiogranuloma and 1:1.5 for peripheral giant cell granuloma with dominant presentation in the maxilla.\[[@ref2][@ref10]\]

Since the histopathological evaluation is the only single most criterions to distinguish them from each other, each of them should be subjected to biopsy for confirmatory diagnosis. Histologically, peripheral fibroma is usually appeared as nodular mass of dense fibrous connective tissue stroma, whereas pyogenic granuloma is appeared to be an angiomatous lesion with numerous small endothelial-lined capillaries. Peripheral ossifying fibroma along with its clinical variants usually has fibroblastic reaction with variable calcification foci which might be irregular dystrophic calcification (peripheral fibroma with calcification) to cementicles (peripheral fibroma with cementification) and bone formation (peripheral fibroma with ossification).\[[@ref2][@ref7][@ref8]\] Peripheral giant cell granuloma appeared to be vascular giant cell lesions.\[[@ref2]\] Peripheral ameloblastoma is the rare, extraosseous, odontogenic, soft-tissue tumor depicting bony erosion in some cases.\[[@ref11]\] Periodic checkups and immunohistochemistry should be done to rule out basal cell carcinoma. All of the lesions discussed above usually do not produce significant radiographic changes as depicted in these case reports except in long-standing cases of peripheral ossifying fibroma and/or peripheral ameloblastoma rarely peripheral giant cell granuloma. These lesions must be managed effectively to reduce the recurrence propensity, especially for peripheral giant cell granuloma.\[[@ref2][@ref3]\] However, these lesions should be excised thoroughly with the special effort for obtaining primary closure of the surgical site so as to facilitate healing and discouraging proliferative granulation tissue formation which heralds early recurrence.\[[@ref2][@ref3]\]

The differential diagnosis should include peripheral fibroma, pyogenic granuloma, peripheral ossifying fibroma, hyperplastic gingival inflammation, hemangioma, metastatic cancer and angiosarcoma, and odontogenic myxoma.\[[@ref4][@ref6][@ref12]\] Although pyogenic granuloma may vary in texture and duration from soft to firm and could be suggestive of fibroma, even fibroma with calcification in long-standing cases.\[[@ref6][@ref12]\] However, pyogenic granuloma is mostly encountered among pregnant patients exclusively in the gingiva.\[[@ref4][@ref6]\] The metastatic tumors of the oral region are uncommon; the attached gingiva is the most commonly affected soft tissue site followed by the tongue.\[[@ref3][@ref4][@ref6]\] Sometimes, hemangioma may mimic gingival growth, so it is necessary to distinguish it from the other lesions.\[[@ref6]\] Diascopy might be helpful in such cases. Therefore, careful clinical evaluation and histopathology would be necessary to effectively manage these lesions.

Conclusion {#sec1-4}
==========

Although most of the gingival overgrowths represent the reactive hyperplasia to dental plaque except for peripheral ameloblastoma, biopsy is necessary in every case for achieving confirmatory diagnosis and making definite management protocol.
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